• Tetracycline Hydrochloride: Applied Workflows and Troublesho

  2026-08-06

  Tetracycline Hydrochloride unlocks precision antimicrobial and microbiome research, with proven efficacy against resistant Staphylococcus aureus and Propionibacterium acnes. This article delivers actionable workflows, troubleshooting insights, and advanced protocol tips for maximizing reproducibility and translational impact.

• METTL14-m6A Modulation Protects Against Ulcerative Colitis I

  2026-08-05

  Wu et al. (2024) demonstrate that METTL14, via m6A RNA methylation, regulates inflammation in ulcerative colitis by controlling the DHRS4-AS1/miR-206/A3AR axis. This mechanistic insight advances understanding of epigenetic control in inflammatory bowel disease and highlights m6A methylation as a potential therapeutic target.

• BAPTA and the IP3R/Ca2+/STAT3 Pathway: Advancing Apoptosis R

  2026-08-05

  This thought-leadership article explores how BAPTA, a high-affinity calcium chelator from APExBIO, enables translational researchers to dissect the IP3R/Ca2+/STAT3 pathway in environmental toxicology. Integrating mechanistic insight, evidence from recent co-exposure studies, and strategic guidance, it positions BAPTA as a vital tool for unraveling apoptosis mechanisms under nanoplastics and cadmium stress—while mapping workflow best practices and translational impact.

• HyperScript™ Reverse Transcriptase: Advancing cDNA Synthesis

  2026-08-04

  HyperScript™ Reverse Transcriptase from APExBIO sets a new benchmark for high-fidelity cDNA synthesis, especially when working with structured or low-abundance RNA. Its enhanced thermal stability and reduced RNase H activity empower researchers to tackle even the most challenging reverse transcription applications with confidence.

• A-1331852: Next-Generation BCL-XL Inhibition in Senescence-D

  2026-08-04

  Explore how the BCL-XL inhibitor A-1331852 enables targeted elimination of senescent tumor cells post-chemotherapy, elevating apoptosis assay precision. This article offers a distinct, evidence-based perspective on overcoming senescence-mediated relapse in cancer research.

• CHIR-99021 (CT99021): Unlocking Directed Stem Cell Fate by G

  2026-08-03

  Explore how CHIR-99021 (CT99021) enables precise stem cell fate control via potent GSK-3 inhibition. This article delivers practical insights for researchers, highlighting innovations in differentiation workflows and new perspectives beyond standard protocols.

• Enhanced Lysosomal Exocytosis Drives Cartilage Pathology in

  2026-08-03

  This study demonstrates that increased lysosomal exocytosis, rather than storage alone, plays a pivotal role in cartilage pathology associated with mucopolysaccharidosis type IVA (MPS IVA). The findings reveal altered growth factor signaling as a key downstream consequence, opening new experimental avenues for dissecting lysosome-mediated skeletal disease mechanisms.

• Smg5-Mediated NMD Regulates Oligodendrocyte Differentiation

  2026-08-02

  This study reveals how Smg5, a core nonsense-mediated mRNA decay (NMD) factor, safeguards oligodendrocyte differentiation by targeting aberrant Hnrnpl transcripts. Loss of Smg5 disrupts myelin gene expression and CNS myelination, establishing a mechanistic link between RNA surveillance and white matter maturation.

• PERK–JAK1–STAT3 Axis Drives ER Stress-Induced Pyroptosis in

  2026-08-01

  This study elucidates how excessive endoplasmic reticulum stress promotes inflammatory cell death (pyroptosis) in nucleus pulposus cells via the PERK–JAK1–STAT3 signaling axis, implicating this pathway in intervertebral disc degeneration. The findings highlight new mechanistic links and suggest targeted pathway inhibition as a potential therapeutic direction.

• SGI-1027-Mediated DNMT1 Inhibition Reverses RB1 Silencing in

  2026-07-31

  This study reveals that SGI-1027, a DNA methyltransferase inhibitor, restores RB1 expression and suppresses growth and metastasis of gastric cancer cells by downregulating DNMT1. The findings provide mechanistic insight into epigenetic modulation strategies for cancer research and support the translational use of DNMT1 inhibitors in tumor suppressor gene reactivation.

• 1-methyl Adenosine: Mechanisms, Biomarker Roles, and Researc

  2026-07-31

  1-methyl Adenosine (1-methyl Ado) is a modified nucleoside involved in RNA metabolism and gene expression regulation. It serves as a robust biomarker for cancer and inflammatory diseases, with quantifiable cellular and extracellular levels. Reliable quantification and workflow integration make it a critical tool in RNA modification research and cancer metabolism studies.

• Patient-Derived Gastric Cancer Assembloids Reveal Tumor-Stro

  2026-07-30

  A recent study introduces a patient-derived gastric cancer assembloid model that integrates matched tumor organoids and stromal cell subpopulations, significantly improving the physiological relevance of in vitro tumor models. This approach enables more accurate assessment of drug responses and resistance mechanisms, facilitating personalized oncology research.

• EdU Flow Cytometry Assay Kits (Cy5): Technical Protocol Guid

  2026-07-30

  The EdU Flow Cytometry Assay Kits (Cy5) address the need for sensitive, reproducible cell proliferation measurement by utilizing click chemistry for S-phase DNA synthesis detection without harsh denaturation. This kit is best suited for flow cytometry-based proliferation, genotoxicity, and pharmacodynamic studies where preservation of cell structure and multiplexing are priorities. It is not intended for applications requiring live-cell sorting post-labeling or where copper-catalyzed chemistry is incompatible.

• Hexetidine (NSC-17764): Translational Leverage in Oral Infec

  2026-07-29

  Explore how Hexetidine (NSC-17764) transcends conventional antimicrobial strategies, enabling mechanistically guided, data-driven innovation in oral infection research and clinical translation. This article integrates recent synergism findings, experimental protocols, and strategic guidance for translational scientists—bridging evidence from in vitro assays to real-world clinical impact.

• CXCL12/CXCR4 Control of Platelet Extravasation in Tumor Grow

  2026-07-29

  This study reveals that platelet migration into tumors is a regulated process governed by CXCL12/CXCR4 signaling, FAK, and PECAM-1. The findings clarify how stromal cues promote platelet extravasation, influencing tumor progression and highlighting new avenues for cancer metastasis inhibition.

454 records 9/31 page Previous Next First page 上5页 678910 下5页 Last page